5
total announcements
531524.BO · 15 min delayed
ICSA (India) Ltd-$
ICSA (India) Ltd has announced unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors considering and approving the same. The company has also disclosed details of its liquidation process, including the sale of assets and distribution of proceeds among stakeholders.
ICSA (India) Ltd-$
ICSA (India) Ltd-$ announces unaudited financial results for the 1st quarter ended June 30, 2026, with revenue and expenses not disclosed. The Board of Directors has approved the results, and a copy of the unaudited financial results along with Limited Review Reports is enclosed. The company is in liquidation, and the National Company Law Tribunal (NCLT) has ordered the liquidation of M/s ICSA (India) Limited. The Liquidator has taken control and custody of the management and operations of the Company, but control and custody of the documents/information was never duly provided by erstwhile management.
ICSA (India) Ltd-$
ICSA (India) Ltd has informed BSE that the meeting of the Board of Directors is scheduled on August 14, 2026, to consider and approve the unaudited standalone financial results for the 1st quarter ended June 30, 2026.
ICSA (India) Ltd-$
The company, ICSA (India) Ltd, has announced the outcome of its board meeting for quarterly results of the CIRP period. The meeting was held on July 29, 2026, and the board considered and approved the financial results for the quarter and half-year ended September 30, 2019.
ICSA (India) Ltd-$
ICSA (India) Ltd has scheduled a Board Meeting on June 25, 2026, to address critical compliance and governance matters. The agenda includes the appointment of statutory and secretarial auditors for the financial years 2019-2026, notably covering a Corporate Insolvency Resolution Process (CIRP) period. Additionally, the board will consider changing the company's registered office within Hyderabad and authorizing the board to resolve pending compliance and legal issues. This indicates a proactive effort to regularize operations and improve corporate hygiene post-CIRP.